TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome

Autoimmunity

Volumn 47, Issue 6, 2014, Pages 389-394

  Firinu, Davide ^a   Barca, Maria Pina ^a   Lorrai, Maria Maddalena ^a   Perra, Silvia ^a   Cabras, Stefano ^a,b   Muggianu, Emma ^a   Di Martino, Maria Luisa ^a   Manconi, Paolo Emilio ^a   Del Giacco, Stefano R ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSIDAD CARLOS III DE MADRID   (Spain)

Author keywords

Autoinflammatory; CRMO; Inflammation; Interleukin 1 ; Osteitis; TH17

Indexed keywords

ADALIMUMAB; CLODRONIC ACID; DOXYCYCLINE; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 17; LEFLUNOMIDE; MACROLIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PREDNISONE; RISEDRONIC ACID;

ADULT; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; PERIPHERAL LYMPHOCYTE; PSORIATIC ARTHRITIS; REMISSION; SAPHO SYNDROME; TH1 CELL; TH17 CELL; TH2 CELL; BIOSYNTHESIS; BLOOD; CELL COUNT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY;

ACQUIRED HYPEROSTOSIS SYNDROME; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; HUMANS; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MIDDLE AGED; TH17 CELLS;

EID: 84904102577     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2014.906582     Document Type: Article

References (34)

1. Nguyen, M. T., A. Borchers, C. Selmi, et al. 2012. The SAPHO syndrome. Semin. Arthritis Rheum. 42: 254-265
2. Van Doornum, S., D. Barraclough, G. McColl, and I. Wicks. 2000. SAPHO: Rare or just not recognized?. Semin. Arthritis Rheum. 30: 70-77
3. Colina, M., C. Pizzirani, M. Khodeir, et al. 2010. Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: Successful treatment with anakinra. Rheumatology (Oxford) 49: 1416-1418
4. Braun-Falco, M., and T. Ruzicka. 2011. Skin manifestations in autoinflammatory syndromes. J. Dtsch. Dermatol. Ges. 9: 232-246
5. Ferguson, P. J., and M. Sandu. 2012. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr. Rheumatol. Rep. 14: 130-141
6. Colina, M., M. Govoni, C. Orzincolo, and F. Trotta. 2009. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A single center study of a cohort of 71 subjects. Arthritis Rheum. 61: 813-821
7. Chiricozzi, A., S. Zhang, A. Dattola, et al. 2012. Role of Th17 in the pathogenesis of cutaneous inflammatory diseases. J. Biol. Regul. Homeost. Agents 26: 313-318
8. Jin, D., L. Zhang, J. Zheng, and Y. Zhao. 2008. The inflammatory Th 17 subset in immunity against self and non-self antigens. Autoimmunity 41: 154-162
9. Leipe, J., M. Grunke, C. Dechant, et al. 2010. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum. 62: 2876-2885
10. Szalay, B., G. Meszaros, A. Cseh, et al. 2012. Adaptive immunity in ankylosing spondylitis: Phenotype and functional alterations of T-cells before and during infliximab therapy. Clin. Dev. Immunol. 2012: 808724. doi: 10.1155/2012/808724
11. Zhang, L., Y. G. Li, Y. H. Li, et al. 2012. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS One 7: E31000
12. Chao, C. C., S. J. Chen, I. E. Adamopoulos, et al. 2011. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis. Autoimmunity 44: 243-252
13. Zhang, L., X. Q. Yang, J. Cheng, et al. 2010. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin. Immunol. 135: 108-117
14. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949
15. Zielinski, C. E., F. Mele, D. Aschenbrenner, et al. 2012. Pathogeninduced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484: 514-518
16. Lasiglie, D., E. Traggiai, S. Federici, et al. 2011. Role of IL-1 beta in the development of human T(H)17 cells: Lesson from NLPR3 mutated patients. PLoS One 6: E20014
17. Ovadia, A., A. Livneh, O. Feld, et al. 2013. T helper 17 polarization in familial Mediterranean fever. Genes Immun. 14: 212-216
18. Benhamou, C. L., A. M. Chamot, and M. F. Kahn. 1988. Synovitisacne- pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies?. Clin. Exp. Rheumatol. 6: 109-112
19. Aerts, N. E., K. J. De Knop, J. Leysen, et al. 2010. Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-Associated chemokine receptor expression. Rheumatology (Oxford) 49: 2264-2272
20. Grosjean, C., M. Hurtado-Nedelec, P. Nicaise-Roland, et al. 2010. Prevalence of autoantibodies in SAPHO syndrome: A single-center study of 90 patients. J. Rheumatol. 37: 639-643
21. Hayem, G., A. Bouchaud-Chabot, K. Benali, et al. 1999. SAPHO syndrome: A long-Term follow-up study of 120 cases. Semin. Arthritis Rheum. 29: 159-171
22. Sonozaki, H., H. Mitsui, Y. Miyanaga, et al. 1981. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann. Rheum. Dis. 40: 547-553
23. Przepiera-Bedzak, H., K. Fischer, and M. Brzosko. 2013. Serum levels of angiogenic cytokines in psoriatic arthritis and SAPHO syndrome. Polskie Archiwum Medycyny Wewnetrznej 123: 297-302
24. Przepiera-Bedzak, H., I. Brzosko, K. Fischer, and M. Brzosko. 2012. Abstracts of the 3rd World Psoriasis & Psoriatic Arthritis Conference 2012: ''Psoriasis-A global health challenge'': Stockholm, Sweden, June 27-July 1, 2012. Dermatol. Ther. 2: S50
25. Wendling, D., C. Prati, and F. Aubin. 2012. Anakinra treatment of SAPHO syndrome: Short-Term results of an open study. Ann. Rheum. Dis. 71: 1098-1100
26. Santarlasci, V., L. Cosmi, L. Maggi, et al. 2013. IL-1 and T helper immune responses. Front Immunol. 4: 182. doi: 10.3389/fimmu.2013.00182
27. Omoyinmi, E., R. Hamaoui, A. Pesenacker, et al. 2012. Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. Rheumatology (Oxford) 51: 1881-1886
28. Koenders, M. I., I. Devesa, R. J. Marijnissen, et al. 2008. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice. Arthritis Rheum. 58: 3461-3470
29. Shepherd, J., M. C. Little, and M. J. Nicklin. 2004. Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J. Invest. Dermatol. 122: 665-669
30. Orru, V., M. Steri, G. Sole, et al. 2013. Genetic variants regulating immune cell levels in health and disease. Cell 155: 242-256
31. Griffin, G. K., G. Newton, M. L. Tarrio, et al. 2012. IL-17 and TNF-Alpha sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J. Immunol. 188: 6287-6299
32. Hurtado-Nedelec, M., S. Chollet-Martin, P. Nicaise-Roland, et al. 2008. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) 47: 1160-1167
33. Pelletier, M., L. Maggi, A. Micheletti, et al. 2010. Evidence for a cross-Talk between human neutrophils and Th17 cells. Blood 115: 335-343
34. Alghasham, A., and Z. Rasheed. 2014. Therapeutic targets for rheumatoid arthritis: Progress promises. Autoimmunity 47: 77-94